Organon & Co. (FRA:7XP)

Germany · Delayed Price · Currency is EUR

6.07

-0.05 (-0.82%)

Last updated: Dec 5, 2025, 8:05 AM CET

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2019 - 2020
Women's Health Revenue	1.82B	1.78B	Log In	Log In	Log In	Upgrade
Biosimilars Revenue	673.00M	662.00M	Log In	Log In	Log In	Upgrade
Established Brands Revenue	3.71B	3.85B	Log In	Log In	Log In	Upgrade
Other Product Group Revenue	94.00M	115.00M	Log In	Log In	Log In	Upgrade
Revenue (Total)	6.30B	6.40B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2019 - 2020
United States Revenue	1.65B	1.57B	Log In	Log In	Log In	Upgrade
Europe and Canada Revenue	1.63B	1.76B	Log In	Log In	Log In	Upgrade
Asia Pacific and Japan Revenue	996.00M	1.05B	Log In	Log In	Log In	Upgrade
China Revenue	840.00M	847.00M	Log In	Log In	Log In	Upgrade
Latin America, Middle East, Russia and Africa Revenue	1.08B	1.03B	Log In	Log In	Log In	Upgrade
Other International Revenue	108.00M	137.00M	Log In	Log In	Log In	Upgrade
International Revenue	4.65B	4.83B	Log In	Log In	Log In	Upgrade
Revenue (Total)	6.30B	6.40B	Log In	Log In	Log In	Upgrade